ACR–ARS PRACTICE PARAMETER FOR THE PERFORMANCE OF TOTAL BODY IRRADIATION

OBJECTIVES This practice parameter was revised collaboratively by the American College of Radiology (ACR) and the American Radium Society (ARS). This practice parameter provides updated reference literature regarding both clinical-based conventional total body irradiation and evolving volumetric modulated total body irradiation. METHODS This practice parameter was developed according to the process described under the heading The Process for Developing ACR Practice Parameters and Technical Standards on the ACR website (https://www.acr.org/Clinical-Resources/Practice-Parameters-and-Technical-Standards) by the Committee on Practice Parameters-Radiation Oncology of the ACR Commission on Radiation Oncology in collaboration with the ARS. RESULTS This practice parameter provides a comprehensive update to the reference literature regarding conventional total body irradiation and modulated total body irradiation. Dependence on dose rate remains an active area of ongoing investigation in both the conventional setting (where instantaneous dose rate can be varied) and in more modern rotational techniques, in which average dose rate is the relevant variable. The role of imaging during patient setup and the role of inhomogeneity corrections due to computer-based treatment planning systems are included as evolving areas of clinical interest notably surrounding the overall dose inhomogeneity. There is increasing emphasis on the importance of evaluating mean lung dose as it relates to toxicity during high-dose total body irradiation regimens. CONCLUSIONS This practice parameter can be used as an effective tool in designing and evaluating a total body irradiation program that successfully incorporates the close interaction and coordination among the radiation oncologists, medical physicists, dosimetrists, nurses, and radiation therapists.

[1]  M. Hurwitz,et al.  ACR–ARS Practice Parameter on Informed Consent Radiation Oncology , 2023, American journal of clinical oncology.

[2]  Xiaomin Lu,et al.  Higher Reported Lung Dose Received During Total Body Irradiation for Allogeneic Hematopoietic Stem Cell Transplantation in Children With Acute Lymphoblastic Leukemia Is Associated With Inferior Survival: A Report from the Children's Oncology Group. , 2019, International journal of radiation oncology, biology, physics.

[3]  K. Dusenbery,et al.  Influence of Total Body Irradiation Dose Rate on Idiopathic Pneumonia Syndrome in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation. , 2019, International journal of radiation oncology, biology, physics.

[4]  I. F. Durmus,et al.  Total-body irradiation using linac-based volumetric modulated arc therapy: Its clinical accuracy, feasibility and reliability. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  Sung-Soo Yoon,et al.  Effect of dose rate on pulmonary toxicity in patients with hematolymphoid malignancies undergoing total body irradiation , 2018, Radiation oncology.

[6]  L. Specht,et al.  Total Body Irradiation: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG). , 2018, International journal of radiation oncology, biology, physics.

[7]  R. Morin,et al.  Image guidance doses delivered during radiotherapy: Quantification, management, and reduction: Report of the AAPM Therapy Physics Committee Task Group 180. , 2018, Medical physics.

[8]  Steve B. Jiang,et al.  Volumetric modulated arc therapy based total body irradiation: Workflow and clinical experience with an indexed rotational immobilization system , 2017 .

[9]  H. Geinitz,et al.  Total body irradiation with volumetric modulated arc therapy: Dosimetric data and first clinical experience , 2016, Radiation Oncology.

[10]  Zhengjia Chen,et al.  Factors Influencing Pulmonary Toxicity in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in the Setting of Total Body Irradiation-Based Myeloablative Conditioning. , 2016, International journal of radiation oncology, biology, physics.

[11]  F. Locatelli,et al.  Early and progressive insulin resistance in young, non‐obese cancer survivors treated with hematopoietic stem cell transplantation , 2015, Pediatric blood & cancer.

[12]  P. Auquier,et al.  Metabolic syndrome in adults who received hematopoietic stem cell transplantation for acute childhood leukemia: an LEA study , 2015, Bone Marrow Transplantation.

[13]  Xiaomin Lu,et al.  Association of higher lung dose received during total body irradiation for allogeneic hematopoetic stem cell transplantation in children with acute lymphoblastic leukemia with inferior progression-free and overall survival: A report from the Children’s Oncology Group. , 2015 .

[14]  J. Cortes,et al.  Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[15]  A. Lane,et al.  Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[16]  L. Jones,et al.  Cardiopulmonary exercise testing prior to myeloablative allo-SCT: a feasibility study , 2014, Bone Marrow Transplantation.

[17]  M. Aristophanous,et al.  SU-E-T-404: Simple Field-In-Field Technique for Total Body Irradiation in Large Patients. , 2014, Medical physics.

[18]  S. Marnitz,et al.  Long-term results of total body irradiation in adults with acute lymphoblastic leukemia , 2014, Strahlentherapie und Onkologie.

[19]  J. Cortes,et al.  Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI. , 2013, Blood.

[20]  J. Dipersio,et al.  Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation. , 2013, Blood.

[21]  M. Engelhard,et al.  Long‐term follow‐up of pediatric patients receiving total body irradiation before hematopoietic stem cell transplantation and post‐transplant survival of >2 years , 2013, Pediatric blood & cancer.

[22]  M. Labopin,et al.  Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  G. Zararsiz,et al.  Comparison of total body irradiation plus cyclophosphamide with busulfan plus cyclophosphamide as conditioning regimens in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplant , 2013, Leukemia & lymphoma.

[24]  K. Ness,et al.  Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease. , 2011, Blood.

[25]  O. Craciunescu,et al.  Severe pulmonary toxicity after myeloablative conditioning using total body irradiation: an assessment of risk factors. , 2011, International journal of radiation oncology, biology, physics.

[26]  S. Tarima,et al.  Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia , 2011, Bone Marrow Transplantation.

[27]  M. Sorror,et al.  Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[28]  H. Deeg,et al.  Solid cancers after allogeneic hematopoietic cell transplantation. , 2009, Blood.

[29]  An Liu,et al.  Image-guided total-marrow irradiation using helical tomotherapy in patients with multiple myeloma and acute leukemia undergoing hematopoietic cell transplantation. , 2009, International journal of radiation oncology, biology, physics.

[30]  Jeffrey S. Miller,et al.  Similar and promising outcomes in lymphoma patients treated with myeloablative or nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[31]  M. Maris,et al.  Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[32]  N. Simone,et al.  Pulmonary function following total body irradiation (with or without lung shielding) and allogeneic peripheral blood stem cell transplant , 2007, Bone Marrow Transplantation.

[33]  C. Sklar,et al.  Final height in pediatric patients after hyperfractionated total body irradiation and stem cell transplantation , 2007, Bone Marrow Transplantation.

[34]  M. Sorror,et al.  Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  S. Hingorani Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: epidemiology, pathogenesis, and treatment. , 2006, Journal of the American Society of Nephrology : JASN.

[36]  Mei-Jie Zhang,et al.  A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[37]  M. Maris,et al.  Treatment for Acute Myelogenous Leukemia by Low-Dose, Total-Body, Irradiation-Based Conditioning and Hematopoietic Cell Transplantation From Related and Unrelated Donors , 2006 .

[38]  M. Hiraoka,et al.  Influence of Radiation Dose Rate and Lung Dose on Interstitial Pneumonitis after Fractionated Total Body Irradiation: Acute Parotitis May Predict Interstitial Pneumonitis , 2006, International journal of hematology.

[39]  B. Afessa,et al.  Acute lung injury after hematopoietic stem cell transplantation. , 2005, Clinics in chest medicine.

[40]  T. Schultheiss,et al.  Dose response and factors related to interstitial pneumonitis after bone marrow transplant. , 2005, International journal of radiation oncology, biology, physics.

[41]  W. Berdel,et al.  Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia. , 2005, Blood.

[42]  Susanta K Hui,et al.  Feasibility study of helical tomotherapy for total body or total marrow irradiationa). , 2005, Medical physics.

[43]  M. Sorror,et al.  Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  S. Carruthers,et al.  Total body irradiation and pneumonitis risk: a review of outcomes , 2004, British Journal of Cancer.

[45]  P. Richardson,et al.  Hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment , 2003, Current opinion in hematology.

[46]  Y. Ikeda,et al.  Granisetron Plus Dexamethasone Versus Granisetron Alone in the Prevention of Vomiting Induced by Conditioning for Stem Cell Transplantation: A prospective Randomized Study , 2003, International journal of hematology.

[47]  J. Gribben,et al.  Effect of total body irradiation dose escalation on outcome following T-cell-depleted allogeneic bone marrow transplantation. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[48]  C. Fiorino,et al.  Lethal pulmonary complications significantly correlate with individually assessed mean lung dose in patients with hematologic malignancies treated with total body irradiation. , 2002, International journal of radiation oncology, biology, physics.

[49]  R. Storb,et al.  Relapse after allogeneic bone marrow transplantation for refractory anemia is increased by shielding lungs and liver during total body irradiation. , 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[50]  J. Bourhis,et al.  Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  V. Budach,et al.  Immediate toxicity during fractionated total body irradiation as conditioning for bone marrow transplantation. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[52]  N. Ramsay,et al.  Patterns of gonadal dysfunction following bone marrow transplantation , 1998, Bone Marrow Transplantation.

[53]  E. Touboul,et al.  Interstitial pneumonitis following autologous bone-marrow transplantation conditioned with cyclophosphamide and total-body irradiation. , 1996, International journal of radiation oncology, biology, physics.

[54]  B. Dubray,et al.  Radiobiological and Clinical Bases for Total Body Irradiation in the Leukemias and Lymphomas. , 1995, Seminars in radiation oncology.

[55]  J. Cosset,et al.  Consequences of two different doses to the lungs during a single dose of total body irradiation: results of a randomized study on 85 patients. , 1994, International journal of radiation oncology, biology, physics.

[56]  E. Touboul,et al.  Total-body irradiation and cataract incidence: a randomized comparison of two instantaneous dose rates. , 1994, International journal of radiation oncology, biology, physics.

[57]  P Genest,et al.  A translating-bed technique for total-body irradiation. , 1994, Physics in medicine and biology.

[58]  P. Cony-Makhoul,et al.  Regimen-related toxicity in patients undergoing BMT with total body irradiation using a sweeping beam technique. , 1992, Bone marrow transplantation.

[59]  David A. Amato,et al.  Fractionation and dose rate effects in mice: a model for bone marrow transplantation in man. , 1987, International journal of radiation oncology, biology, physics.

[60]  H. Deeg,et al.  Marrow transplantation for acute nonlymphoblastic leukemia in first remission: toxicity and long-term follow-up of patients conditioned with single dose or fractionated total body irradiation. , 1986, Bone marrow transplantation.

[61]  J. V. Dyk,et al.  The physical aspects of total and half body photon irradiation : a report of Task Group 29, Radiation Therapy Committee, American Association of Physicitst in Medicine , 1986 .

[62]  E. Podgoršak,et al.  Interstitial pneumonitis following total body irradiation for bone marrow transplantation using two different dose rates. , 1985, International journal of radiation oncology, biology, physics.

[63]  C. Song,et al.  Effect of fractionation and rate of radiation dose on human leukemic cells, HL-60. , 1985, Radiation research.

[64]  R. Storb,et al.  Marrow transplantation for acute nonlymphoblastic leukemic in first remission using fractionated or single-dose irradiation. , 1982, International journal of radiation oncology, biology, physics.

[65]  J. Williamson,et al.  Basic data for dosage calculation and compensation. , 1980, International journal of radiation oncology, biology, physics.

[66]  N. Puente Duany,et al.  [Total body irradiation]. , 1950, Boletin de la Liga Contra el Cancer. Liga Contra el Cancer.